Identification

Generic Name
Tin protoporphyrin IX
DrugBank Accession Number
DB16449
Background

Not Available

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 785.71
Monoisotopic: 785.051664
Chemical Formula
C34H32Cl3N4O4Sn
Synonyms
  • Sn Protoporphyrin
  • Sn-heme
  • SnPP
  • SnPP Protoporphyrin
  • Tin protoporphyrin IX
External IDs
  • GTPL5279
  • Q27088994

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action

SnPP is a competitive inhibitor of heme oxygenase, an enzyme which degrades heme to bilirubin, prevents the development of hyperbilirubinemia, and reduces bilirubin levels in plasma. This compound is also found to directly inactivate DENV and YFV infectious particles and has the potential to have antiviral activity against numerous organisms.

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
DIO3JT9G2P
CAS number
14325-05-4
InChI Key
KXYSGXXTXAHPIX-UHEVNVKKSA-J
InChI
InChI=1S/C34H34N4O4.2ClH.Sn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;;/h7-8,13-16,35,38H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42);2*1H;/q;;;+4/p-4/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;;;
IUPAC Name
SMILES
[Cl-].[Cl-].[Sn+4].CC1=C(CCC([O-])=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C=C)=C4C)/C(C)=C3CCC([O-])=O

References

General References
  1. Nagae H, Keino H, Watanabe K, Kashiwamata S: Pharmacological and biological effects of tin-protoporphyrin on neonatal hyperbilirubinemic Gunn rats. Pediatr Res. 1988 Aug;24(2):209-12. doi: 10.1203/00006450-198808000-00014. [Article]
  2. Johnson ACM, Delrow JJ, Zager RA: Tin protoporphyrin activates the oxidant-dependent NRF2-cytoprotective pathway and mitigates acute kidney injury. Transl Res. 2017 Aug;186:1-18. doi: 10.1016/j.trsl.2017.05.005. Epub 2017 May 19. [Article]
  3. Pibiri M, Leoni VP, Atzori L: Heme oxygenase-1 inhibitor tin-protoporphyrin improves liver regeneration after partial hepatectomy. Life Sci. 2018 Jul 1;204:9-14. doi: 10.1016/j.lfs.2018.05.011. Epub 2018 May 5. [Article]
  4. Neris RLS, Figueiredo CM, Higa LM, Araujo DF, Carvalho CAM, Vercoza BRF, Silva MOL, Carneiro FA, Tanuri A, Gomes AMO, Bozza MT, Da Poian AT, Cruz-Oliveira C, Assuncao-Miranda I: Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope. Sci Rep. 2018 Jun 28;8(1):9805. doi: 10.1038/s41598-018-27855-7. [Article]
ChemSpider
81367143

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Not Yet RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19)1
1WithdrawnPreventionAcute Kidney Injury (AKI)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00596 mg/mLALOGPS
logP5.67ALOGPS
logS-5.1ALOGPS
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at January 21, 2021 01:43 / Updated at December 23, 2021 07:46